It has been proposed that OX 1 orexin receptors and CB 1 cannabinoid receptors can form heteromeric complexes, which affect the trafficking of OX 1 receptors and potentiate OX 1 receptor signaling to extracellular signal-regulated kinase (ERK). We have recently shown that OX 1 receptor activity releases high levels of the endocannabinoid 2-arachidonoyl glycerol (2-AG), suggesting an alternative route for OX 1 -CB 1 receptor interaction in signaling, for instance, in retrograde synaptic transmission. In the current study, we set out to investigate this possibility utilizing recombinant Chinese hamster ovary K1 cells. 2-AG released from OX 1 receptor-expressing cells acted as a potent paracrine messenger stimulating ERK activity in neighboring CB 1 receptor-expressing cells. When OX 1 and CB 1 receptors were expressed in the same cells, OX 1 stimulation-induced ERK phosphorylation and activity were strongly potentiated. The potentiation but not the OX 1 response as such was fully abolished by specific inhibition of CB 1 receptors or the enzyme responsible for 2-AG generation, diacylglycerol lipase (DAGL). Although the results do not exclude the previously proposed OX 1 -CB 1 heteromerization, they nevertheless unequivocally identify DAGL-dependent 2-AG generation as the pivotal determinant of the OX 1 -CB 1 synergism and thus suggest a functional rather than a molecular interaction of OX 1 and CB 1 receptors.
Introduction
Neuropeptides orexin-A and -B are best known for their roles in the regulation of sleep/wakefulness and appetite, but many other prominent functions have also been described (reviewed in Aston-Jones et al., 2010; Scammell and Winrow, 2011; Kukkonen, 2013; Perez-Leighton et al., 2012) . Orexins mediate their actions via rhodopsin family G-protein-coupled receptors (GPCRs) named OX 1 and OX 2 , which can be found in the central nervous system (CNS) but also in other parts of the body (reviewed in Scammell and Winrow, 2011; Kukkonen, 2013) . Orexin receptor activation leads to signaling via multiple intracellular pathways (reviewed in Kukkonen, 2013) . In neurons, activation of orexin receptors usually leads to depolarization through inhibition of K 1 channels or activation of nonspecific cation channels (reviewed in Kukkonen, 2013) . Intracellular Ca 21 concentration is elevated through both Ca 21 release and Ca 21 influx, and other potently activated targets include phospholipases C (PLC), D, and A 2 . Mitogen-activated protein kinase pathways ERK1/2 (extracellular signal-regulated kinase 1/2) and p38 may also be important signal relayers in orexin signaling (Hilairet et al., 2003; Ammoun et al., 2006a, b; Shin et al., 2009; reviewed in Kukkonen, 2013) . The main G-protein pathway for orexin receptors is assumed to be G q , but other G-protein couplings have also been seen (reviewed in Kukkonen, 2013) . Endocannabinoids are locally released lipid metabolites that regulate a wide variety of processes in the CNS, including analgesia, mood, reward, memory, appetite, and energy metabolism (reviewed in Kano et al., 2009 ). The best known endocannabinoids are 2-arachidonoylglycerol (2-AG) and anandamide (reviewed in Di Marzo and Petrosino, 2007) . The cannabinoid receptors CB 1 and CB 2 also belong to the GPCRs of the rhodopsin subfamily, and they predominantly couple to G i/o proteins (reviewed in Pertwee, 1997; Alexander and Kendall, 2007) . CB 1 receptors are mainly found in the CNS neurons. A central feature of the endocannabinoid system in the CNS is its involvement in retrograde synaptic transmission. In this process, PLC activation and/or Ca 21 elevation in the postsynaptic neuron induces local production and release of endocannabinoids that inhibit neurotransmitter release from the presynaptic neuron via action on presynaptic CB 1 receptors (Ohno-Shosaku et al., 2001 ; reviewed in Kano et al., 2009) . Like orexin receptors, CB 1 receptors are known to use the ERK pathway in their signaling, in addition to the more often described inhibitory actions on adenylyl cyclase or voltage-gated Ca 21 channels or activation of K 1 channels (Bouaboula et al., 1995; Felder et al., 1995; reviewed in Alexander and Kendall, 2007; Kano et al., 2009; Turu and Hunyady, 2010) . The physiologic functions regulated by endocannabinoids and orexins are partially overlapping, as is their gross localization in the brain, for instance, in lateral hypothalamus (see, e.g., Herkenham et al., 1991; Nambu et al., 1999; Marcus et al., 2001; Wittmann et al., 2007; Palkovits et al., 2008; Suarez et al., 2011) , although the endocannabinoid system is much more widespread in the brain than the orexinergic system (Herkenham et al., 1991; reviewed in Kukkonen et al., 2002; Laitinen, 2004; Freund et al., 2003; Kano et al., 2009) . Some studies implicate an interaction between orexinergic and cannabinoidergic systems (reviewed in Kukkonen, 2013) . For instance, in rat dorsal raphe nucleus, orexin-B-mediated inhibition of glutamate release can be ascribed to 2-AG release and action on CB 1 receptors on presynaptic terminals (Haj-Dahmane and Shen, 2005) . Orexin-A-induced analgesic response in rat periaqueductal gray relies on 2-AG-mediated retrograde inhibition of g-aminobutyric acid release (Ho et al., 2011) . Heterologous coexpression of OX 1 and CB 1 receptors in Chinese hamster ovary (CHO) cells very strongly potentiates OX 1 receptor signaling to ERK (Hilairet et al., 2003) . This potentiation has been interpreted to be due to heterodimerization of OX 1 and CB 1 receptors. Further studies have continued along this same line and assessed, by different means, the heterodimerization/-oligomerization of these two receptors (Ellis et al., 2006; Ward et al., 2011) .
We have recently shown that the endocannabinoid 2-AG is strongly produced and released in OX 1 receptor signaling, and that this 2-AG is able to act as a potent paracrine messenger via CB 1 receptors (Turunen et al., 2012) . This, together with the studies in the CNS, suggests that 2-AG production is an important signal in orexin-mediated regulation of synaptic transmission. Therefore, the observed potentiation of OX 1 receptor-mediated ERK phoshorylation upon OX 1 -CB 1 receptor coexpression could be due to CB 1 receptor activation by 2-AG instead of receptor di-/oligomerization. In the current study, we set out to resolve this issue; the results show that 2-AG produced through OX 1 receptor action is a central mediator of the potentiation.
Materials and Methods
Drugs. 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide (AM-251), 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide (SR141716; a.k.a. SR-141716A or rimonabant), and 3-(1,19-dimethylheptyl)-6aR,7,10,10aR-tetrahydro-1-hydroxy-6,6-dimethyl-6H-dibenzo [b, were from Cayman Europe (Tallinn, Estonia). Human orexin-A and -B were from NeoMPS (Strasbourg, France), N,N,N,-trimethyl-4-(2-oxo-1-pyrrolidinyl)-2-butyn-1-ammonium iodide (oxotremorine-M) was from RBI (Natick, MA), and Cell Culture. CHO-hOX 1 cells, expressing human OX 1 receptors, have been described previously, as have their culture conditions (see, e.g., Turunen et al., 2010 Turunen et al., , 2012 . CHO-hCB 1 cells, expressing human CB 1a receptor (Grimsey et al., 2010) , were a kind gift from Dr. Michelle Glass (University of Auckland, Auckland, New Zealand) via Drs. Jarmo Laitinen and Juha Savinainen (University of Eastern Finland, Kuopio, Finland); the culture conditions for these have been described (Turunen et al., 2012) . For Western blotting (WB) experiments, the cells were cultured on six-well plates (9.6-cm 2 well bottom area; Greiner Bio-One GmbH, Frickenhausen, Germany); for the luciferase assays, on either 24-or 96-well plates (Greiner Bio-One GmbH); and for the receptor binding experiments, on cell culture dishes (56-cm 2 bottom area) or 48-well plates (Greiner Bio-One GmbH). Sf9 insect cells (for baculovirus propagation) were cultured in shaker culture as described in Näreoja et al. (2011) .
Plasmids and Transfection. The plasmid pSG-GalElk-1 (fusion of the dimerization domain of the transcription factor Elk-1 and the DNA-binding domain of the yeast transcription factor Gal4) (Kortenjann et al., 1994 ) was a kind gift from Dr. Peter E. Shaw (Queen's Medical Centre, Nottingham, UK), pGL3 G5 E4 D38 (5Â Gal4 binding site controlling firefly luciferase expression) (Kamano et al., 1995) . Empty plasmids were used to keep DNA amount equal in all transfections.
Transient transfection was used for the Elk-1 activity assay in CHO-hOX 1 and CHO-hCB 1 cells and for the PLC activity assay and binding experiments, which were to be performed in the same conditions. In addition to the reporter assay plasmids (pSG-GalElk-1, pGL3 G5 E4 D38, pRL-TK), CB 1 receptor (pcDNA3.1-3HA-hCB 1 with CHO-hOX 1 cells), OX 1 receptor (pcDNA3.1-hOX 1 with CHOhCB 1 cells), or M 1 receptor (pM 1 -GFP with CHO-hCB 1 cells) (or empty plasmid) was used. Cells on 96-well plates were grown to 40250% confluence and transfected in Ham's F-12 with 0.312 mg/cm 2 DNA and 0.74 ml/cm 2 FugeneHD (Roche, Mannheim, Germany). The optimized transfection conditions used for DNA were 0.6% (w/v) pSG-GalElk-1, 50% pGL3 G5 E4 D38, 2.4% pRL-TK, and 47% pcDNA3.1-3HA-hCB 1 / pcDNA3.1-hOX 1 /pM 1 -GFP/empty plasmid. Liposome-based delivery was used in this assay as several plasmids had to be cotransfected, which is more easily accomplished by this technique than using the baculovirus system (below).
Elk-1 Activity Luciferase Assay. The cells were transfected as described above, and 5 hours after transfection they were washed and changed to serum-free medium to serum-starve the cells overnight. The following day, the cells were stimulated. When inhibitors were used, they (or the vehicle) were added to the cells 30 minutes prior to orexin-A, HU-210, or 2-AG. After 5 hours of stimulation, the cells were lysed and the assay continued essentially according to the instructions of the manufacturer of the assay kit (Dual-Luciferase Reporter Assay system; Promega). Luminescence was measured with GloMax 20/20 luminometer (Promega). The Elk-1-specific signal (firefly luciferase) was normalized to Renilla luciferase in each sample. The Elk-1 reporter assay was specific for ERK since it was fully inhibited by U0126, an inhibitor of the upstream activator of ERK, MEK1 (MAPK/ERK kinase 1) (not shown).
Elk-1 activity assay was also used for measurement of paracrine communication from CHO-hOX 1 cells to CHO-hCB 1 cells via 2-AG release, similar to a previously described cAMP assay (Turunen et al., 2012) . Briefly, CHO-hCB 1 cells on cell culture dishes were transfected with the Elk-1 reporter plasmids (pSG-GalElk-1, pGL3 G5 E4 D38, and pRL-TK). Five hours later, they were detached [phosphatebuffered saline (PBS) 1 0.02% (w/v) EDTA], spun down, mixed with an equal amount of nontransfected CHO-hOX 1 , and plated on a 24-well plate. The following evening, they were serum-starved as above. The following morning (48 hours after transfection), the "cell mixture" was stimulated and the luciferase activities measured as above.
Baculoviral Vectors and Transduction. Generation of baculovirus expression vectors for mammalian expression of GFP as well as human C-terminally GFP-tagged OX 1 receptor (OX 1 -GFP) under cytomegalovirus promoter has been previously described . For a similar construct of CB 1 receptor (CB 1 -GFP), the fragment of pcDNA3.1-CB 1 -GFP containing the cytomegalovirus promoter and the CB1-GFP fusion was ligated in pFastBac with Rapid DNA Ligation Kit (Thermo Scientific, Rockford, IL). Recombinant baculovirus was obtained using the Bac-to-Bac Expression System (Invitrogen, Carlsbad, CA). The virus stocks were propagated in Sf9 insect cells.
Baculovirus transduction was used for transient "second" receptor expression for WB analysis of ERK1/2 phosphorylation. Baculovirus was used for WB assays due to its ease, economy, and 100% transduction efficiency. High-titer virus stocks obtained from Sf9 cells were cleared by centrifugation, resuspended in the cell culture medium, and added to CHO cells on six-well plates . The cells were used 24 or 48 hours later as described below.
ERK1/2 Phosphorylation (Activation) Assay. CHO cells were transduced with recombinant baculovirus vectors containing OX 1 -GFP or CB 1 -GFP constructs; baculovirus expressing only GFP was used as a negative control. In the final experiments, only CHO-hCB 1 cells transduced with OX 1 -GFP constructs were used. Transduction was done as follows. CHO-hCB 1 cells were plated on six-well plates (3 Â 10 6 cells/well) and cultured overnight (to 40260% confluence). The following day, the cells were transduced with OX 1 -GFP baculovirus. The virus-containing medium was removed 5 hours later, and the cells were washed with PBS and left in serum-free medium to be used the following day.
The ERK phosphorylation experiments were performed largely as described in Ammoun et al. (2006a) with some modifications. Inhibitors (THL, SR141716, and vehicle control) were added to the cells in serum-free culture medium 30 minutes prior to stimulation. The cells were stimulated with orexin-A, 2-AG, or HU-210 for 10 minutes and rapidly lysed with 100 ml of lysis buffer [50 mM Hepes, 150 mM NaCl (pH 7.5) 1 10% (v/v) glycerol, 1% (v/v) Triton X-100, 1.5 mM MgCl 2 , 1 mM EDTA, 10 mM Na 1 -pyrophosphate, 1 mM Na 1 -orthovanadate, 10 mM NaF, 250 mM p-nitrophenol phosphate, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, and PhosSTOP phosphatase inhibitor cocktail (Roche)]. The samples were boiled in Laemmli sample buffer [50 mM Tris-HCl (pH 6.8) 1 1 mM dithiothreitol, 2% (w/v) sodium dodecyl sulfate, 10% (v/v) glycerol, and 0.1% (w/v) bromophenol blue] and separated on 10% polyacrylamide gel by electrophoresis. Protein was transferred to nitrocellulose membranes (Hybond-C Extra Nitrocellulose; Amersham Biosciences, Little Chalfont, Bucks, UK), which were then washed with PBS and blocked with a 50:50 mixture of Odyssey blocking buffer (Li-cor Biosciences, Lincoln, NE) and PBS 1 0.1% (v/v) Tween 20 for 1 hour. Membranes were then incubated with primary antibodies overnight at 14°C. Primary antibodies used were rabbit anti-active MAPK IgG (1:5000; #V803A; Promega) and mouse p44/42 MAPK (ERK1/2) IgG (1:2500; #46965; Cell Signaling Technology, Danvers, MA) in a 50:50 mixture of Odyssey blocking buffer and PBS 1 0.1% (v/v) Tween 20. The following day, the membranes were washed with PBS (3 times, 10 minutes each) and incubated with infrared fluorescent secondary antibodies for 1 hour at room temperature, protected from light. Secondary antibodies used were DyLight 800-conjugated goat anti-rabbit IgG (1:10,000; #35571; Li-cor) and DyLight 680-conjugated goat anti-mouse IgG (1:10,000; #35518; Li-cor). After incubation with secondary antibodies, the membranes were washed with PBS (3 times, 10 minutes each) before detecting the bands with Odyssey Infrared Imaging System (Li-cor). The images were analyzed using Nikon NIS-Elements AR (Nikon, Tokyo, Japan).
Within an experiment, each gel included a standard (in duplicate) composed of 100 nM orexin-A in control cells from the same stock material (see Supplemental Fig. 2 ). The intensity of each gel was additionally normalized according to these lanes to compensate for possibly uneven protein transfer.
Adenylyl Cyclase Activity. The measurements were performed essentially as described in Turunen et al. (2012) . CHO-hCB 1 cells on 24-well plates were prelabeled with [ 3 H]adenine for 2 hours, after which they were washed once with Hepes-buffered medium (HBM; composition in mM: NaCl, 137; KCl, 5; CaCl 2 , 1; MgCl 2 , 1.2; KH 2 PO 4 , 0.44; NaHCO 3 , 4.2; glucose, 10; and Hepes, 20; adjusted to pH 7.4 with NaOH) and then preincubated in HBM containing 500 mM 3-isobutyl-1-methylxanthine (a cyclic nucleotide phosphodiesterase inhibitor) and 0.5 mg/ml stripped bovine serum albumin [BSA; to help to retain 2-AG in solution (Savinainen et al., 2003) ] 6 THL for 30 minutes at 37°C. The stimulants (forskolin, 2-AG) were added and the reactions allowed to proceed for 10 minutes, after which they were interrupted by rapid removal of the medium, addition of ice-cold perchloric acid, and freezing. After thawing, cell debris was spun down and the PLC Activity. Total inositol phosphate release was measured essentially as described in Jäntti et al. (2012) . CHO-hCB 1 cells were transiently transfected with either OX 1 or M 1 cDNA and also the other vectors included in the Elk-1 luciferase assay in the same ratios to make the assays comparable. Five hours later, the cells were exposed to [ 3 H]inositol to prelabel the membrane phosphoinositides. After 16 hours of labeling, the cells were washed once with HBM and incubated in HBM containing 10 mM LiCl (to inhibit inositol monophosphatase) for 10 minutes at 37°C. The cells were then stimulated with orexin-A for 20 minutes. The reactions were stopped by rapid removal of the medium, addition of 0.2 ml of 0.4 M ice-cold perchloric acid, and freezing. Thawed samples were neutralized with 0.1 ml of 0.36 M KOH 1 0.3 M KHCO 3 . The insoluble fragments were spun down and the total inositol phosphate fraction isolated by anionexchange chromatography. The radioactivity of the inositol phosphate fraction was determined using scintillation counting as above.
Receptor Binding. Receptor expression levels were determined by radioligand binding. [ 125 I]Orexin-A was used for OX 1 receptors. The cells were plated on cell culture dishes and transfected (if relevant for the assay) the following day. The cDNA mixtures contained the different vectors in the same ratios as for the Elk-1 luciferase assay to make the assays comparable. After yet another 24 hours, the cells were detached (PBS 1 0.02% EDTA), spun down, and resuspended in HBM containing 0.1% (w/v) BSA. The binding assay was performed in this buffer in low-protein-binding tubes (Eppendorf Nordic Aps, Horsholm, Denmark) with [ 125 I]orexin-A at room temperature. The nonspecific binding was determined with 10 mM CB 1 Receptor Signaling Potentiates OX 1 Receptor Signaling SB-334867 (preincubated for 10 minutes before orexin-A). The reaction was allowed to proceed for 10 minutes, after which the cells were rapidly spun down (12°C, 14,000g, 30 seconds). The pellet was washed superficially (no resuspension) with ice-cold HBM and resuspended in HBM, and the radioactivity counted (Wallac Wizard 1480 Gamma Counter; PerkinElmer).
[ 125 I]Orexin-A has several complicating properties (Kukkonen, 2012 (Kukkonen, , 2013 , and the assay conditions were thus carefully optimized. Due to its high filter binding, the separation of bound and free radioligand is not possible by filtration (Holmqvist et al., 2001; Kukkonen, 2012 ; J. Putula and J. P. Kukkonen, unpublished) , and centrifugation of cells in suspension was thus rather applied. BSA and low-protein-binding tubes and pipette tips were used to reduce binding of orexin-A to plastic surfaces. Orexin-A (as well as [ 125 I]orexin-A) is an agonist and stimulates receptor internalization. Cell-surface-bound orexin-A was dissociated upon exposure to lowpH, urea-containing buffer (Chang et al., 1993) and the internalized radioligand seen after the NaOH incubation following this wash. At 10 minutes, very little internalization was seen. Thus, binding under these conditions reflects cell-surface rather than total receptor expression.
CB 1 receptor expression was measured in cells attached on polyethylenimine-coated (25 mg/ml for 1 hour at 37°C; SigmaAldrich) 48-well plates (Greiner). The cells were transfected as above and used 24 hours later. The cells were incubated in HBM containing 0.1% (w/v) BSA 1 [ 3 H]SR141716 (6 10 mM HU-210 to determine nonspecific binding) for 60 minutes at room temperature. The plates were placed on ice, the medium rapidly removed, the wells washed rapidly twice with ice-cold HBM, the cells detached with NaOH, and their radioactivity measured by scintillation counting (PerkinElmer). Both the radioligand and all available nonlabeled ligands to determine nonspecific binding are cell-permeable and can thus not separate cell-surface and intracellular binding. Data Analysis. All data are presented as mean 6 S.E.M.; n refers to the number of batches of cells (and equals the number of independent experiments). Each experiment was performed at least three times, and the averaged data presented are thus from at least three independent experiments. WB experiments were performed with two, Elk-1-luciferase measurements with three, and cAMP measurements with four data points in parallel. Student's paired or nonpaired two-tailed t test with Bonferroni correction was used in all pairwise comparisons.
Results
The aim of the study was to investigate the molecular mechanism behind the previous finding of strong potentiation of OX 1 orexin receptor-induced ERK activity by CB 1 cannabinoid receptor coexpression. For the studies, we used two stable cell lines expressing human OX 1 and CB 1 receptors, CHO-hOX 1 and CHO-hCB 1 cells, respectively. These cells were additionally transiently transfected or transduced to express CB 1 and OX 1 (or M 1 ) receptors, respectively (Supplemental Fig. 1 ). ERK activity was assessed by WB against the phosphorylated (active) ERK and downstream activity of the ERK target, transcription factor Elk-1.
CHO-hCB 1 Cells with Transient Expression of OX 1 Receptors Show CB 1 Receptor Signaling-Dependent Potentiation of OX 1 Signaling to ERK. In CHO-hCB 1 cells, CB 1 receptor stimulation with 2-AG or HU-210 produced an ERK1/2 phosphorylation response, as assessed by WB with antibodies against phosphorylated (active) ERK (Fig. 1A) . There was no ERK phosphorylation in response to orexin stimulation in CHO-hCB 1 cells (Fig. 1A) , but when OX 1 receptors were transiently expressed in these cells utilizing baculovirus, orexin-A produced a marked response (Fig. 1B) . The same was seen in the Elk-1 activity assay (Fig. 1C) .
Orexin-A produced a concentration-dependent stimulation of ERK phosphorylation in transiently OX 1 -expressing CHOhCB 1 cells (Fig. 2, A and B ; Supplemental Fig. 2 ; Supplemental Table 1 ). When CB 1 receptors were blocked with the CB 1 Fig. 1 . pERK and Elk-1 activity responses in CHO-hCB 1 cells expressing OX 1 receptors upon transduction or transfection. ERK phosphorylation in response to CB 1 receptor stimulation with HU-210 or 2-AG or orexin receptor stimulation with orexin-A in native CHO-hCB 1 cells (A) and in cells transduced with OX 1 -GFP baculovirus (B). The results come from infrared fluorescence, and thus the figures appear inverted as compared with film images. Also, the dynamic range is much wider than on the film or can be shown here; a compromise in terms of the intensity had to be made to present the data here. (C) Responses in CHO-hCB 1 cells transfected with OX 1 cDNA with respect to the Elk-1 activity assay (n = 5). **P , 0.01 vs basal. receptor antagonist/inverse agonist SR141716, the maximum response to orexin-A was strongly reduced (Fig. 2 , A-C; Supplemental Fig. 2 ). An equal inhibition was seen with the diacylglycerol lipase (DAGL) inhibitor THL (Fig. 2 , A-C; Supplemental Fig. 2 ). The potency of orexin-A was also reduced 100-to 150-fold by SR141716 and THL (Fig. 2, A Tables 1 and 2) .
Elk-1 was activated by orexin-A with somewhat lower potency than ERK phosphorylation in CHO-hCB 1 cells transiently expressing OX 1 receptors ( Fig. 3 ; Supplemental Table 1 ). The DAGL inhibitor THL and another CB 1 receptor antagonist, AM-251, produced a 5-to 8-fold reduction in the potency of orexin-A (Fig. 3, A and E; Supplemental Tables 1  and 2 ), but there was no difference in the basal (Fig. 3C) or the maximum response (Fig. 3D) .
M 1 Muscarinic Receptor Response Is More Weakly Potentiated Than the OX 1 Receptor Response. We expressed another strongly G q -PLC-coupled receptor, human M 1 muscarinic acetylcholine receptor, in CHO-hCB 1 cells and assessed Elk-1 activity as for the OX 1 receptor. Stimulation with the potent agonist oxotremorine-M produced a clear concentration-dependent Elk-1 activation (Fig. 3B) . Inclusion of THL and AM-251 slightly reduced the maximum response as well as slightly shifted the concentration-response curve (Fig. 3, B, D , and E). The shift in the concentration-response curve by THL and AM-251 was significantly smaller for M 1 than for the OX 1 receptors (Fig. 3D ). This indicates that the M 1 response is more weakly potentiated by CB 1 receptor signaling than the OX 1 response, despite the fact that both receptors produced essentially equal PLC activation (Fig. 3F) . AM-251 clearly reduced the basal Elk-1 activity in M 1 -expressing cells, unlike in OX 1 -expressing cells (Fig. 3C) .
CB 1 Expression on CHO-hOX 1 Background Potentiates the ERK Pathway. Orexin-A produced a concentration-dependent stimulation of Elk-1 activity in CHO-hOX 1 cells ( Fig. 4A ; Supplemental Table 1) . No response to the CB 1 cannabinoid receptor stimulus (HU-210) was seen (not shown). Upon transient expression of CB 1 receptors, HU-210 was able to induce Elk-1 activity (not shown; see below for Fig. 6B ). Transient expression of CB 1 receptors increased the potency of orexin-A 6-fold; this was fully blocked by THL or AM-251 (Fig. 4 , A and D; Supplemental Tables 1 and 2 ). CB 1 expression did not affect the maximum response (Fig. 4C) . Interestingly, the basal Elk-1 activity was elevated by CB 1 receptor coexpression (Fig. 4B) . This was clearly more efficiently inhibited by AM-251 than THL, and may thus relate to constitutive activity of CB 1 receptors (see, e.g., Turunen et al., 2012). Supplementary Fig. 2 . The basal ERK phoshorylation was very low (see also Fig. 1, A and B, and Supplementary Fig. 2) , and thus the basal is normalized to 0 for the curves. (C and D) Average responses (n = 3). The data were normalized to the noninhibited CB 1 -OX 1 control in each batch of cells before averaging. *P , 0.05, **P , 0.01, ***P , 0.001 vs. controls.
DAGL Inhibitor THL and CB 1 Receptor Antagonist/ Inverse Agonist AM-251 Do Not Show Nonspecific Effects. As a control, we tested the drugs used for nonspecific effects. THL did not have any direct blocking effect on CB 1 receptor signaling, and similarly, THL and AM-251 were devoid of an effect on OX 1 orexin receptor or M 1 muscarinic receptor signaling (Fig. 5) , which is in agreement with previous findings (see Discussion) .
The Impact of the Receptor Stoichiometry on the CB 1 Receptor Potentiation of OX 1 Signaling. Potentiation of ERK signaling was obtained upon combination of OX 1 and CB 1 receptors on either cell background (CHO-hCB 1 and CHOhOX 1 , respectively), but the potentiation was somewhat more modest when CB 1 receptors were transiently expressed on the CHO-hOX 1 background (compare Figs. 3 and 4) . Interestingly, the pEC 50 value of orexin-A for ERK phosphorylation or Elk-1 activation in both stable CHO cell clones was around 7.4-7.8 when CB 1 receptors were not present or when they were inhibited (THL or CB 1 antagonist; Supplemental Table 1) .
When the responses to OX 1 and CB 1 receptor stimulation were compared between the cell types, it was clearly seen that the maximal CB 1 and OX 1 receptor activation equally strongly stimulated Elk-1 activity in CHO-hCB 1 1 OX 1 cells (Fig. 6, A and C) , whereas OX 1 receptors much more strongly stimulated Elk-1 activity in CHO-hOX 1 1 CB 1 cells (Fig. 6, B and C). The efficacy of the synergistic signaling of OX 1 and CB 1 receptors could be imagined to relate to the receptor expression levels and stoichiometry. High OX 1 expression might give a more robust 2-AG production, which is able to stimulate CB 1 receptors even not in immediate vicinity of OX 1 receptors. Efficient CB 1 signaling, as indicated by the receptor's ability to connect to the ERK cascade when stimulated directly (HU-210), should suggest good ability to potentiate the orexin response. We thus measured the apparent expression levels of OX 1 and CB 1 receptors in the different cell systems utilizing the same expression of constructs as for the Elk-1 assay, to make the results as comparable as possible. The protocol applied (see Receptor Binding) visualizes, for OX 1 receptors, the cell-surface expression. The binding was for CHO-hOX 1 cells 460 6 30 fmol/mg protein (n 5 3) (Fig. 6D) . Transient expression of CB 1 receptor in these cells did not significantly alter the OX 1 expression. CHO-hCB 1 cells transiently transfected with OX 1 receptor cDNA expressed very low levels of OX 1 receptors (22 6 3 fmol/mg protein; n 5 5) (Fig. 6D) . It should be pointed out that [ 125 I]orexin-A binding only indicates the so-called agonist high-affinity sites and not the total receptor pool (Kukkonen, 2004) . In contrast, the total CB 1 receptor pool (both cell surface and internal, both agonist affinity states) is visualized by [ 3 H]SR141716 binding (Fig. 6E) . This binding amounted to 3.2 6 0.3 pmol/mg protein in CHO-hCB 1 cells. Transient expression of OX 1 in these cells slightly elevated Average responses (n = 3). The data were normalized to the noninhibited CB 1 -OX 1 control in each batch of cells before averaging. The first comparisons are to the corresponding controls. *P , 0.05, **P , 0.01, ***P , 0.001 vs. controls. In (D), the second comparison is to the control CHO-hOX 1 cells (no CB 1 expression). NS, not significant (P . 0.05).
CB 1 expression (Fig. 6E ). Transient CB 1 expression level in CHO-hOX 1 cells was significantly lower than the stable expression in CHO-hCB 1 cells (Fig. 6E) . THL did not affect OX 1 or CB 1 expression levels (Fig. 6, D and F) . Although the receptor expression levels (Fig. 6C ) affect the responses obtained by stimulation of OX 1 and CB 1 receptors (Fig. 6F) , the potentiation works equally well at very low OX 1 receptor expression levels (CHO-hCB 1 1 OX 1 cells) and thus also over a wide range of OX 1 -CB 1 receptor stoichiometries (Fig. 6F) .
OX 1 Receptor Signaling Relays Endocannabinoid Signals via CB 1 Receptor to ERK Also in Paracrine Fashion. The results thus suggest that OX 1 receptor signaling releases 2-AG via DAGL (as we have recently shown in Turunen et al., 2012) , 2-AG acts in an autocrine manner on the coexpressed CB 1 receptors, and these, synergistically with the OX 1 receptors, activate the ERK cascade. We have recently presented an artificial cell-cell communication assay between OX 1 -expressing and CB 1 -expressing cells via 2-AG release (i.e., retrograde synaptic transmission) using adenylyl cyclase regulation in CHO-hCB 1 cells as the output (Turunen et al., 2012) . We wanted to test here whether the 2-AG released would be able to activate the ERK cascade too. Indeed, the 2-AG released from CHO-hOX 1 cells upon exposure to orexin-A was an effective stimulant of the ERK cascade in nearby CHO-hCB 1 cells (Fig. 7) . The response obtained was sensitive to THL and AM-251 (Fig. 7) , as expected (Turunen et al., 2012) .
Discussion
We have recently shown that OX 1 receptor stimulation in CHO cells induces significant endocannabinoid 2-AG production by activating DAGL (Turunen et al., 2012 ). In the current study, we show that this 2-AG is able to act both as auto-and paracrine messenger on CB 1 cannabinoid receptors. If the receptors are expressed in the same cells, OX 1 receptor signaling to the ERK cascade is strongly potentiated by autocrine CB 1 signaling. The potentiation is fully reversed by blocking CB 1 receptors with SR141716 or AM-251 or inhibition of DAGL with THL. This shows that the potentiation requires OX 1 receptor-induced release of 2-AG, which acts via CB 1 receptors.
Our findings are centrally based on the inhibitors THL, SR141716, and AM-251. THL was originally used as triglyceride lipase inhibitor, but was later found to be an even more potent inhibitor of DAGLa and -b (Bisogno et al., 2003; Szabo et al., 2006) . Most importantly, we have recently shown that THL at 1 mM fully blocks 2-AG production in CHO cells (Turunen et al., 2012) . THL displays weak affinity for CB 1 receptors too (K i % 4 mM) (Szabo et al., 2006) , but this is too low to cause any significant inhibition of CB 1 receptors here (see also Fig. 5 ). We also tried overexpression of monoacylglycerol lipase, but did not obtain strong enough reduction in 2-AG levels (not shown). Whether this is due to low expression or lack of an activation signal remains elusive. SR141716 has mainly been used as a CB 1 receptor antagonist/inverse agonist in the previous studies on OX 1 -CB 1 interaction (Hilairet et al., 2003; Ellis et al., 2006; Ward et al., 2011) , and we thus used it in the ERK phosphorylation assay. As an additional level of control, we used another well known CB 1 receptor antagonist/inverse agonist, AM-251, in the Elk-1 activity assay. Both ligands behaved in a similar manner and showed no nonspecific effects, despite the fact that AM-251 is actually an inverse agonist. DAGL block by THL and CB 1 receptor block with AM-251 or SR141716 produce an essentially equal inhibition of the potentiation of ERK signaling, and thus the putative constitutive activity of CB 1 receptors seems largely redundant for the agonist-stimulated ERK activity.
The two assays used to measure ERK activation produced qualitatively equal potentiation-i.e., CB 1 receptor coexpression with OX 1 receptors always potentiated OX 1 signaling to CB 1 Receptor Signaling Potentiates OX 1 Receptor Signaling ERK-but the level of potentiation was lower for the Elk-1 activity assay and the maximum response was not affected in CHO-hCB 1 cells. The assays are run for very different times, 10 minutes and 5 hours for pERK and Elk-1, respectively. One explanation for the result is that the temporal profile of ERK activation is different in the absence and presence of CB 1 receptor signaling, e.g., that the CB 1 receptor contribution ceases faster than the OX 1 receptor component. Another explanation readily at hand is that Elk-1 response saturates at submaximal ERK activation levels. For ERK signaling there is the complicating factor of possible different cytosolic and nuclear ERK activity.
Potentiation of the ERK signaling of OX 1 receptors by CB 1 receptor coexpression has been previously observed in CHO cells (Hilairet et al., 2003) . The potentiation was found to be blocked by the CB 1 antagonist SR141716 and pertussis toxin. The authors inferred, based on colocalization studies, that OX 1 and CB 1 receptors form heteromeric complexes with enhanced signaling capabilities (Hilairet et al., 2003) . In the current study, we have assessed the ERK signaling cascade and can show that 2-AG, produced by OX 1 receptor activity, signals to ERK via CB 1 receptors (Fig. 7) and also mediates the potentiation when the receptors are expressed in the same cells. Also, the other findings of Hilairet et al. (2003) -that CB 1 receptor stimulation-induced ERK phosphorylation is not affected by OX 1 receptor coexpression and OX 1 -mediated PLC activation is not potentiated by CB 1 coexpression-are likely explained by this signaling scheme. Since there is no PLC coupling of CB 1 receptors, PLC activity cannot be potentiated, and OX 1 receptor coexpression does not potentiate CB 1 receptor coupling to ERK, since CB 1 receptor activation does not produce any ligand for OX 1 receptors.
The concept of OX 1 -CB 1 receptor heterodimerization was further refined by Milligan and coworkers in their work with HEK-293 cells (Ellis et al., 2006) . In these cells, potentiation of ERK phosphorylation is very weak (Ellis et al., 2006) . We have not investigated OX 1 -CB 1 signaling in HEK-293 cells, but it is possible that the weak potentiation of the ERK response could be due to much lower or less potent 2-AG production upon OX 1 receptor activation in this cell type as compared with CHO cells, as is also indicated by our recent findings (Turunen et al., 2012) ; however, we have not had access to the same clone of HEK-293 cells. This group has also presented convincing Förster (fluorescence) resonance energy transfer and immunoprecipitation data on OX 1 -CB 1 complex formation (Ward et al., 2011) . Thus, there is little doubt that these receptors have the capacity to combine into heteromers like many other GPCRs (reviewed in Birdsall, 2010; . Previously, CB 1 receptors have been reported to interact with many other GPCRs via either dimerization or functional interaction (Glass and Felder, 1997; Rios et al., 2006; Harkany et al., 2007; Marcellino et al., 2008; Turu et al., 2009; . We have no means of readily inhibiting the receptor heteromerization process, and we therefore cannot assess the significance of this for the potentiation of ERK signaling. However, we currently feel that the most important interaction between OX 1 and CB 1 receptors takes place via OX 1 receptor-stimulated 2-AG production, i.e., a functional interaction, which, theoretically, would not demand receptor complex formation. However, it is possible that functional interaction via endocannabinoids and receptor heteromerization collaborate. If receptor heteromers were placed in signaling complexes including PLC, DAGL, and the putative 2-AG extrusion machinery, CB 1 receptors would be exposed to highest possible 2-AG levels. This would be an attractive hypothesis, but at least in CHO-hOX 1 cells 2-AG production is high enough to even allow diffusion in the extracellular space (Fig. 7) (Turunen et al., 2012) , as also should be the case for the retrograde synaptic transmission.
Potentiation of ERK signaling by CB 1 receptors also works well at very low orexin receptor expression levels. The high OX 1 receptor level in CHO-hOX 1 cells may thus be to a large part superfluous with respect to 2-AG generation for autocrine CB 1 receptor stimulation. Orexin receptor coupling to the PLC cascade is very efficient, similar to what we have previously found for muscarinic receptors (Kukkonen et al., 1996) . OX 1 receptors also potently coupled to the ERK-Elk-1 cascade even at low expression levels. CB 1 receptors were efficiently expressed both stably and transiently; some receptor reserve may also exist for CB 1 receptors, as indicated by the similar Elk-1 response in these different cell types. The cell-surface receptor levels are likely significantly lower than measured here, as CB 1 receptors often show a high degree of constitutive internalization (Ellis et al., 2006) . We could not, unfortunately, directly assess this, as the binding assay does not allow separation of cell-surface and intracellular receptors. However, local receptor levels in synaptic areas are also high. Fig. 7 . Elk-1 data from CHO-hOX 1 cell-CHOhCB 1 cell communication assay (see Elk-1 Activity Luciferase Assay). Elk-1-driven luciferase activity was measured in CHO-hCB 1 cells interspersed among CHO-hOX 1 cells stimulated with orexin-A. Inhibition of the luciferase activity with THL and AM-251 indicates that the Elk-1 activity is induced by the cascade orexin-A → OX 1 receptors (on CHO-hOX 1 cells) →→ 2-AG (extracellular) → CB 1 receptors (on CHO-hCB 1 cells) (n = 4) (Turunen et al., 2012) . ***P , 0.001 vs. basal. ns, not significant (P . 0.05).
If the potentiation of ERK signaling by OX 1 -CB 1 "collaboration" solely takes place via functional interaction of the signal pathways, what then are the molecular mechanisms? Orexin receptors are suggested to be able to interact with at least G i/o , G q , and G s family G proteins (Randeva et al., 2001; Holmqvist et al., 2005; Karteris et al., 2005) . However, both G i/o -and G s couplings appear rather weak, at least in CHO cells (Holmqvist et al., 2005) . In contrast, CB 1 receptors strongly couple to G i/o proteins, although other couplings have also been suggested (reviewed in Pertwee, 1997; Alexander and Kendall, 2007 ; see also Fig. 5) . It is thus likely that the two receptors preferentially use different pathways to ERK, and these pathways could act synergistically to activate ERK. Interestingly, the signaling of M 1 muscarinic receptors was only weakly potentiated by CB 1 receptor signaling, although both M 1 and OX 1 receptors equally strongly coupled to the PLC cascade in transient expression. Whether this is due to differences in complexing with CB 1 receptors or efficacy of 2-AG production remains unknown. However, it would be tempting to speculate that the coupling of OX 1 receptors to receptor-activated Ca 21 influx may produce stronger DAGL stimulation than that obtained with muscarinic receptors (Magga et al., 2006; Johansson et al., 2007) .
In conclusion, we have here shown that the critical determinant of the synergistic OX 1 -CB 1 signaling to ERK is the communication cascade OX 1 → DAGL → 2-AG → CB 1 receptors, which allows both OX 1 and CB 1 receptors to simultaneously signal to ERK. Whether receptor heteromerization takes part in the process cannot be resolved, but the data indicate that this may not be needed. However, it is of interest, in future studies, to focus on the possible effects of 2-AG on receptor dimerization, trafficking, and other properties described to be affected upon OX 1 -CB 1 coexpression. Supplemental Fig. 2 . WBs from a representative experiment made with CHO-hCB 1 cells transduced with OX 1 -GFP baculovirus. Please observe that the results come from infrared fluorescence and thus the figures appear inverted as compared to film images. Also, the dynamic range is much wider than on the film or can be shown here; a compromise what concerns the intensity had to be made in order to present the data here.
